Is Indoco Remedies Limited a good investment? Indoco Remedies Limited (INDOCO.NS) is currently trading at 248.80 INR. Market analysts have a consensus price target of 276.25 INR. This suggests a potential upside from current levels.
Earnings Schedule: Indoco Remedies Limited is expected to release its next earnings report on July 28, 2026. The market consensus estimate for Forward EPS is 13.60.
For income investors, Indoco Remedies Limited pays a dividend yield of 0.10%. With a payout ratio of -2%, the dividend appears sustainable.
Yes, it pays an annual dividend of 0.20 INR (0.10% yield).
Indoco Remedies Limited is classified as a Stock. You can compare it against its peer in the "Related Symbols" list.
The next earnings date is projected to be July 28, 2026. The company currently has a trailing EPS of -10.70.
Indoco Remedies Limited manufactures and markets formulations and active pharmaceutical ingredients in India and internationally. It offers products for gastrointestinal, anti-infectives, respiratory, stomatological, vitamins/minerals/nutrients, urological, ophthal/ontological, dermatology, pain/analgesic, cardiac, anti-diabetic, and gynaecological therapeutic areas. The company also provides branded generics comprising analgesic tablets and topical preparations; anti-hypertensive; protein supplements; multivitamin tablets and syrups; antibiotic tablets, syrups, and injectables; oral rehydration powders; antacids; and antihistaminic, anti-inflammatory drugs, etc. In addition, it provides analytical services, such as impurity profile, particle size analysis, polymorphism and compatibility studies, heavy metal analysis, extractables and leachables studies, lyophilization studies, reference and working standards, forced degradation studies, and chromatographic method development and validation services. Further, the company offers architectural design, lighting, mechanical and utility engineering, project and construction management, electrical, control system, piping, structural design, data transfer system, and process engineering. Additionally, it provides contract research services, such as custom chemical synthesis of molecules and intermediates; process chemistry research and development; non-infringing process designing and scale up; and analytical method development, validation, impurity characterization, and polymorphic studies, solutions, as well as intellectual property management. The company was formerly known as Indo Continental Trading Company. Indoco Remedies Limited was founded in 1945 and is based in Mumbai, India.
| Year | Total Dividends |
|---|---|
| ▸2026 |
0.21 INR
|
| Oct. 12, 2026 (estimated) | 0.2111 |
| ▸2025 |
0.20 INR
|
| Oct. 11, 2025 | 0.2000 |
| ▸2024 |
1.50 INR
|
| Oct. 26, 2024 | 1.5000 |
| ▸2023 |
2.25 INR
|
| Oct. 26, 2023 | 2.2500 |
| ▸2022 |
2.25 INR
|
| Oct. 22, 2022 | 2.2500 |
| ▸2021 |
1.50 INR
|
| Oct. 23, 2021 | 1.5000 |
| ▸2020 |
0.30 INR
|
| Oct. 24, 2020 | 0.3000 |
| ▸2019 |
0.30 INR
|
| Sept. 24, 2019 | 0.3000 |
| ▸2018 |
1.00 INR
|
| Oct. 11, 2018 | 1.0000 |
| ▸2017 |
1.60 INR
|
| Sept. 8, 2017 | 1.6000 |
| ▸2016 |
1.60 INR
|
| Aug. 28, 2016 | 0.2000 |
| May 1, 2016 | 1.4000 |
| ▸2015 |
1.60 INR
|
| Aug. 29, 2015 | 1.6000 |
| ▸2014 |
1.40 INR
|
| July 18, 2014 | 1.4000 |
| ▸2013 |
1.10 INR
|
| Aug. 29, 2013 | 1.1000 |
| ▸2012 |
1.10 INR
|
| Aug. 29, 2012 | 1.1000 |
| ▸2011 |
1.07 INR
|
| Aug. 27, 2011 | 1.0667 |
| ▸2010 |
0.93 INR
|
| Aug. 21, 2010 | 0.9333 |
| ▸2009 |
0.70 INR
|
| Oct. 18, 2009 | 0.2667 |
| Jan. 1, 2009 | 0.4333 |
| ▸2008 |
1.53 INR
|
| Nov. 1, 2008 | 0.6667 |
| Jan. 1, 2008 | 0.8667 |
| ▸2006 |
0.83 INR
|
| Nov. 1, 2006 | 0.8333 |
| ▸2005 |
0.67 INR
|
| Oct. 2, 2005 | 0.6667 |
| Name | Payment Date | Status | Amount |
|---|---|---|---|
| Indoco Remedies Limited | Oct 11, 2025 | Paid | 0.2 INR |
| Split Date | Split Ratio to 1 |
|---|---|
| May 17, 2012 | 5.000000 |
Community Discussion